found that the baseline bone marrow tumor burden, CRS severity, and serum biomarker levels (including max lg CRP, IL-10, IFNγ, ferritin, and D-dimer levels) were associated with the incidence of PHT in R/R ALL. The gene discussed is CRP; the disease is neoplasm.